Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Acquisitions (Details Textual)

v3.3.0.814
Note 2 - Acquisitions (Details Textual) - USD ($)
3 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Developed Technology [Member]    
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 18 years  
Trade Names [Member]    
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 20 years  
Customer Relationships [Member]    
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 4 years  
Cliniqa [Member]    
Revenue, Net $ 3,400,000  
Net Income (Loss) Attributable to Parent (400,000)  
Amortization of Intangible Assets 700,000  
Fair Value Write-Up of Acquired Inventory 300,000  
Revenue, Net 112,381,000 $ 108,477,000
Net Income (Loss) Attributable to Parent 22,707,000 23,907,000
Amortization of Intangible Assets 7,411,000 5,728,000
Fair Value Write-Up of Acquired Inventory $ 1,113,000 $ 3,167,000